Ferric derisomaltose and tranexamic acid, combined or alone, for reducing blood transfusion in patients with hip fracture (the HiFIT trial): a multicentre, 2 × 2 factorial, randomised, double-blind, controlled trial

https://www.thelancet.com/journals/lanhae/article/PIIS2352-3026(23)00163-1/fulltext?dgcid=hubspot_update_feature_updatealerts_lanhae&utm_campaign=update-lanhae&utm_medium=email&_hsmi=273659398&_hsenc=p2ANqtz-_IOp9rZeusrA-1cyKYOXQKFz3JSp3W_sv1R90uxtr44HU4OIdrvYoVMvz9yLFeR2KdJbr1xybwNj9uL3W3qxVVMEJdzw&utm_content=273482960&utm_source=hs_email